Cannon Global Investment Management »

Crescent Biopharma shares owned by Cannon Global Investment Management

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Cannon Global Investment Management from 13F filings

Historical chart of Cannon Global Investment Management investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Cannon Global Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Cannon Global Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $187k 10k 18.37

More positions owned by Cannon Global Investment Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Norfolk Southern (NSC)
Terns Pharmaceuticals (TERN)
Sun Communities (SUI)
Madrigal Pharmaceuticals (MDGL)
Cheniere Energy Com New (LNG)
Qiagen Nv Ord Shares (QGEN)
Zoom Communications Cl A (ZM)
Cantor Equity Partners I Shs Cl A (CEPO)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Marvell Technology (MRVL)
Cantor Equity Partners Ii In Cl A Ord Shs (CEPT)
Renatus Tactical Acquis Shs Cl A (RTAC)
Ss&c Technologies Holding (SSNC)

View all positions for Cannon Global Investment Management

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
Tang Capital Management
Vanguard Capital Management
Vanguard Group
Logos Global Management
Deep Track Capital
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma